
Abortion pill maker enters legal battle over FDA rules
The company, GenBioPro, filed a motion on Tuesday in the United States District Court for the Northern District of Texas, Amarillo Division, asking to be added to the list of defendants in a case seeking to restrict access to the abortion drug mifepristone.
If a judge grants the company its request, it means the company would be allowed to lead the case's defense.
The case, called Missouri et al v. FDA, is a revamped version of a lawsuit filed by anti-abortion groups and doctors in 2023 seeking to block the Food and Drug Administration's (FDA) approval of the abortion medication.
After the Supreme Court decided to uphold access to mifepristone last year, the challenge was revived by conservative attorneys general in Missouri, Kansas and Idaho, directly challenging GenBioPro's approval of its generic version of mifepristone.
Those states want the FDA to ban telehealth prescriptions for mifepristone, ban the drug's use after seven weeks of pregnancy and prevent pharmacies from dispensing the drug.
'We remain concerned about extremists and special interests' attempts to undermine the US Food and Drug Administration's regulatory authority,' said GenBioPro CEO Evan Masingill in a statement.
'All people have a right to access safe, affordable, evidence-based health care, and GenBioPro remains committed to using all legal and regulatory tools to protect mifepristone for millions of patients and providers across the country,' he continued.
'Despite the overwhelming majority of Americans—including constituents of these attorneys general—supporting the legal right to abortion, these politicians remain determined to severely restrict access to a critical drug that Americans depend on,' said Skye Perryman, president and CEO of Democracy Forward which is representing GenBioPro in its case along with lawyers from Arnold & Porter.
'Their baseless attacks not only jeopardize the availability of mifepristone, but also threaten the integrity of our nation's drug regulation system,' Perryman added.
Medication abortions typically require the use of two drugs: mifepristone, which blocks the hormone needed for a pregnancy to continue and misoprostol, which induces contractions in the uterus to empty it.
Most abortions in the U.S. are medication abortions with the method making up 63 percent of all abortions in the country in 2023, according to reproductive health research group The Guttmacher Institute.
The FDA approved BioGenPro's generic form of mifepristone, mifepristone tablets 200 mg, in 2019.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
4 minutes ago
- Yahoo
‘What The F**k?': Jon Stewart Stunned By 2 Words In Trump's Latest Epstein Denial
'Daily Show' host Jon Stewart didn't find President Donald Trump very convincing in his latest attempt to downplay his association with late convicted sex offender Jeffrey Epstein. And it came down to two words. Stewart rolled footage of Trump in Scotland trying to deflect questions about his ties to Epstein, saying he had ended his friendship with Epstein because 'he did something that was inappropriate.' Stewart was ready to give the president some credit. 'You see, Donald Trump recognized that Epstein had finally crossed a line,' Stewart said. 'Now, if it were me, obviously giving this explanation in front of reporters, I probably would have stopped there.' But Trump didn't stop there. The 'inappropriate' behavior was Epstein hiring some of Trump's employees. 'He stole people that worked for me,' Trump complained. And Trump still didn't stop there. 'Here comes my favorite part of the defense,' Stewart said. 'Trump's ego and narcissism are so central to his being that even his denial of going to the island comes with a caveat.' Trump insisted he never visited Epstein's infamous private island linked to his sex trafficking ― but did so with those two unexpected words. 'I never had the privilege of going to his island,' Trump said. 'The privilege?' Stewart repeated. 'What the fuck?' Check out the full monologue below:


Bloomberg
4 minutes ago
- Bloomberg
Kremlin Is Silent on New Trump Deadline Russia Is Likely to Snub
Donald Trump's decision to sharply curtail a deadline for Vladimir Putin to halt his war in Ukraine is being met by silence in the Kremlin so far, though analysts say it won't pressure the Russian president into changing course. The US president threatened Monday to impose sanctions within 10-12 days on countries buying Russian exports including energy unless Putin accepts a ceasefire, instead of the 50 days he announced earlier this month. 'There's no reason to wait. If you know what the answer is,' Trump said, voicing frustration at Putin's repeated rejection of his calls for a truce.


Newsweek
36 minutes ago
- Newsweek
Donald Trump Quashes China Summit Rumors: 'No Interest'
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Donald Trump has rejected reports that he is seeking a summit with China's president Xi Jinping. In a post on Truth Social, he said: "The Fake News is reporting that I am SEEKING a 'Summit' with President Xi of China. This is not correct, I am not SEEKING anything! I may go to China, but it would only be at the invitation of President Xi, which has been extended. Otherwise, no interest! Thank you for your attention to this matter." The comments follow claims that discussions were underway over a potential meeting when Trump travels to Asia later this year. Reuters reported that there have been discussions about a possible stopover during the Asia-Pacific Economic Cooperation summit in South Korea in November. Any meeting would be the first face-to-face encounter between Trump and Xi during his second term, which has been marked by heightened tensions over trade. President Donald Trump at a meeting with Prime Minister Keir Starmer in Scotland on Sunday. President Donald Trump at a meeting with Prime Minister Keir Starmer in Scotland on is a developing story. More to follow.